Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Someone with a lot of money to spend has taken a bullish stance on NVIDIA (NASDAQ:NVDA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

GT Biopharma: Q1 Earnings Insights

GT Biopharma (NASDAQ:GTBP) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Aprea Therapeutics Q1 Earnings

Aprea Therapeutics (NASDAQ:APRE) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Sunworks Clocks 406% Revenue Growth In Q1

Sunworks, Inc (NASDAQ:SUNW) reported a first-quarter FY21 revenue growth of 405.7% year-on-year to $31.2 million, beating the consensus of $28.7 million. The increase was mainly due to increased contributions from the Residential segment. The gross margin improved by 4,351 bps to 45%, attributable to the positive contribution from Solcius' business model and operational…

Benzinga

Short Volatility Alert: Criteo S.A.

On Friday, shares of Criteo S.A. (NASDAQ: CRTO) experienced volatile short activity. After the activity, the stock price went down -0.51% to $25.23. The overall sentiment for CRTO has been Bearish.

Benzinga

Short Volatility Alert: Allena Pharmaceuticals

On Friday, shares of Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) experienced volatile short activity. After the activity, the stock price went down -8.27% to $0.122. The overall sentiment for ALNA has been Neutral.

Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping around 70 points on Monday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

You Ask, We Analyze: The Bull And Bear Case For Sundial Growers Stock

On Sunday evening, Benzinga asked its followers on Twitter what they’re buying at the open on Monday. From the replies, Benzinga selected one ticker for technical analysis. @JustaLowlife03 is buying Sundial Growers, Inc (NASDAQ: SNDL).

Benzinga

QuickLogic's Earnings: A Preview

QuickLogic (NASDAQ:QUIK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that QuickLogic will report an earnings per share (EPS) of $-0.07.

Benzinga

Earnings Preview For Greenlane Holdings

Greenlane Holdings (NASDAQ:GNLN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Greenlane Holdings will report an earnings per share (EPS) of $-0.07.

Benzinga

Earnings Preview For Vascular Biogenics

Vascular Biogenics (NASDAQ:VBLT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Vascular Biogenics will report an earnings per share (EPS) of $-0.11.

Benzinga

A Preview Of Bio-Path Holdings's Earnings

Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Bio-Path Holdings will report an earnings per share (EPS) of $-0.45.

Benzinga

Earnings Preview For Agilysys

Agilysys (NASDAQ:AGYS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Agilysys will report an earnings per share (EPS) of $0.17.

Benzinga

Where Netflix Stands With Analysts

Within the last quarter, Netflix (NASDAQ:NFLX) has observed the following analyst ratings:

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Roku Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Roku (NASDAQ:ROKU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Earnings Outlook For Allot

Allot (NASDAQ:ALLT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Allot will report an earnings per share (EPS) of $-0.27.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Upgrades

Benzinga

Expert Ratings for PLBY Group

PLBY Group (NASDAQ:PLBY) has observed the following analyst ratings within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Real Good Food's Return On Capital Employed Overview

Benzinga Pro data, The Real Good Food (NASDAQ:RGF) reported Q4 sales of $25.61 million. Earnings fell to a loss of $44.92 million, resulting in a 279.58% decrease from last quarter.

Benzinga

Looking Into Amarin Corp's Return On Capital Employed

Amarin Corp (NASDAQ:AMRN) brought in sales totaling $94.63 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 314.74%, resulting in a loss of $31.56 million.

Benzinga

Marriott International's Return on Invested Capital Insights

According to Benzinga Pro, during Q1, Marriott International (NASDAQ:MAR) earned $377.00 million, a 19.44% increase from the preceding quarter. Marriott International's sales decreased to $4.20 billion, a 5.56% change since Q4.

Benzinga

Looking Into Blucora's Return On Capital Employed

According to Benzinga Pro, during Q1, Blucora (NASDAQ:BCOR) earned $34.62 million, a 246.11% increase from the preceding quarter. Blucora also posted a total of $307.55 million in sales, a 72.46% increase since Q4.

Benzinga

Regeneron Pharmaceuticals Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Regeneron Pharmaceuticals (NASDAQ:REGN) posted Q1 earnings of $973.50 million, an increase from Q4 of 56.33%. Sales dropped to $2.96 billion, a 40.13% decrease between quarters.

Benzinga

What's Going On With Netflix Shares Today?

Netflix Inc (NASDAQ: NFLX) shares are trading higher Monday following an upgrade from Wedbush. Wedbush analyst Michael Pachter upgraded Netflix from a Neutral rating to an Outperform rating, citing potential for better-than-expected second-quarter results.

Benzinga

Aquestive Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Aquestive Therapeutics's (NASDAQ:AQST) reported sales totaled $12.27 million. Despite a 54.33% increase in earnings, the company posted a loss of $13.22 million.

1 … 525 526 527 528

People

Michael Pachter

39 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Covid-19

31,341 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.